PTGS2 and colorectal carcinoma: These finding are consistent with previous data demonstrating the importance of the PGE2/COX2 system from tumors’ escape from immunosurveillance [38,39,40,41] These data, although preliminary, suggest a potential immunomodulatory mechanism underlying the clinical benefits of aspirin in CRC cancer patients and may warrant further investigation.